Synergistic effect of probiotic and postbiotic on attenuation of PM2.5-induced lung damage and allergic response

Yi-Heng Chiu1,2, Hung-Pin Chiu2, Meei-Yn Lin1

  • 1Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, ROC, Taiwan.

Journal of Food Science
|December 4, 2022
PubMed

Insights

This study shows that combining probiotics and postbiotics synergistically reduces lung damage and allergic responses caused by PM2.5 air pollution in mice. This combination therapy offers a promising approach for managing PM2.5-induced lung injury.

Area of Science:

  • Microbiology
  • Immunology
  • Environmental Health

Background:

  • Air pollution, specifically PM2.5, is a significant cause of lung inflammation and allergic responses.
  • The therapeutic potential of postbiotics, and their synergistic effects with probiotics, in mitigating air pollution-induced lung damage remains largely unexplored.
  • Existing treatments for PM2.5-induced allergies may not be optimal due to the unique immune response triggered by particulate matter.

Purpose of the Study:

  • To investigate the individual and combined effects of probiotics and postbiotics on PM2.5-induced lung inflammation and allergic responses in a mouse model.
  • To evaluate the synergistic potential of combining probiotic and postbiotic treatments.
  • To explore a novel therapeutic strategy for PM2.5-induced lung injury.

Main Methods:

  • Establishment of a mouse model with acute lung damage and allergic response induced by intratracheal administration of PM2.5.
  • Treatment groups included individual probiotic, individual postbiotic, and a combination of both.
  • Assessment of outcomes included body weight changes, IgE levels, and the IFN-γ/IL-4 ratio.

Main Results:

  • Both individual probiotic and postbiotic treatments significantly reduced PM2.5-induced body weight loss and IgE expression.
  • The combination treatment demonstrated synergistic effects, significantly enhancing IgE reduction (57.1%), body weight loss improvement (78.3%), and boosting the IFN-γ/IL-4 ratio (87.5%).
  • Individual treatments did not significantly alter the IFN-γ/IL-4 ratio, highlighting the synergistic benefit of the combination.

Conclusions:

  • Combination therapy of probiotics and postbiotics exhibits a synergistic effect in attenuating PM2.5-induced lung damage and allergic responses.
  • This research suggests a novel platform for the application, formulation, and selection of postbiotics for treating PM2.5-induced lung injury.
  • Modulating immune homeostasis through combined probiotic and postbiotic administration offers a promising therapeutic avenue for air pollution-related respiratory complications.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.4K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
411
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
396
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
512